Dow Down 0.99% Nasdaq Down 0.94%

AcelRx Pharmaceuticals, Inc. (ACRX)

-NasdaqGM
5.40 Down 0.09(1.64%) 11:56AM EDT - Nasdaq Real Time Price
Prev Close:5.49
Open:5.47
Bid:5.41 x 100
Ask:5.42 x 900
1y Target Est:11.33
Beta:1.97
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:5.37 - 5.60
52wk Range:5.27 - 13.64
Volume:394,987
Avg Vol (3m):1,188,570
Market Cap:234.24M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACRX

Comparison

Symbol% ChgMkt Cap
ACRXDown 1.64%234.24M
BAXDown 0.43%38.71B
CFNUp 0.06%9.18B
HSPDown 0.19%8.76B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.07
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AcelRx Pharmaceuticals, Inc., a development stage specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain (BTP). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback